Home 
FOR AUTHORS Neoplasma 2017 Neoplasma Vol.64, No.4, p.571-578, 2017
FOR AUTHORS Neoplasma 2017 Neoplasma Vol.64, No.4, p.571-578, 2017
Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.64, No.4, p.571-578, 2017 |
||
| Title: Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes | ||
| Author: M. Dostalova Merkerova, A. Hrustincova, Z. Krejcik, H. Votavova, E. Ratajova, J. Cermak, M. Belickova | ||
| Abstract: Circulating microRNAs (miRNAs) are non-coding RNAs secreted into body fluids, and aberrant levels of these miRNAs correlate with diseases of various origins, making them highly potential clinical biomarkers. We investigated the spectrum of circulating miRNAs in the plasma of myelodysplastic syndrome (MDS) patients to identify miRNAs showing discriminatory levels in the patients with different prognosis. Plasma samples were analyzed with microarrays to define miRNA profiles, and the deregulated miRNAs were further studied using droplet digital PCR. With regard to the prognosis, the levels of miR-27a-3p, miR-150-5p, miR-199a-5p, miR-223-3p and miR-451a were reduced in higher-risk MDS. Multivariate analysis indicated miR-451a level as an independent predictor of progression-free survival (HR = 0.072, P = 0.006) and revealed a significant association of miR-223-3p level with overall survival (HR = 0.039, P = .032). Our data demonstrate that plasma levels of specific miRNAs are associated with MDS patient outcome and may add information beyond the currently used scoring systems. |
||
| Keywords: circulating miRNA, myelodysplastic syndromes, plasma, progression, microarray | ||
| Published online: 11-Jul-2017 | ||
| Year: 2017, Volume: 64, Issue: 4 | Page From: 571, Page To: 578 | |
| doi:10.4149/neo_2017_411 |
||
|
|
 download file |
|